目的:探究衰弱对社区获得性肺炎患者的临床疗效及生活质量的影响。方法:选取2022年1月至2023年8月期间我院收治的60例获得性肺炎患者作为研究对象。按照患者的衰弱表型评估方法(Fried衰弱评估)评分是否小于3分将患者分为非衰弱组(n=23)...目的:探究衰弱对社区获得性肺炎患者的临床疗效及生活质量的影响。方法:选取2022年1月至2023年8月期间我院收治的60例获得性肺炎患者作为研究对象。按照患者的衰弱表型评估方法(Fried衰弱评估)评分是否小于3分将患者分为非衰弱组(n=23)和衰弱组(n=37)。根据《中国成人社区获得性肺炎诊断和治疗指南》的建议,对患者采取相应的治疗措施。比较两组患者临床疗效、临床症状消退时间、肺功能[第1秒用力呼气量(First second forced expiratory volume,FEV1)、用力肺活量(Forced vital capacity,FVC)及FEV1与FVC的比值(Ratio of FEV1 to FVC,FEV1/FVC)]、生活质量[生活质量量表(SF-36)]的差异。结果:治疗后4 w,衰弱组的总有效率明显低于非衰弱组(P<0.05);衰弱组患者的临床症状消失时间明显长于非衰弱组(P<0.05);两组患者FEV1、FVC、FEV1/FVC肺功能明显高于治疗前,但衰弱组明显低于非衰弱组(P<0.05);衰弱组患者的生活质量指标评分明显低于非衰弱组(P<0.05)。结论:针对社区获得性肺炎患者,衰弱对临床疗效有负面影响,会延长患者的临床症状消退时间,影响患者肺功能恢复,降低患者的生活质量。展开更多
Insulin-like growth factor binding-protein-7 (IGFBP7) was obtained from our previous colonic adenocarcinoma (CRC) and normal mucosa suppression subtraction hybridization (SSH) cDNA libraries. By RT-PCR and immun...Insulin-like growth factor binding-protein-7 (IGFBP7) was obtained from our previous colonic adenocarcinoma (CRC) and normal mucosa suppression subtraction hybridization (SSH) cDNA libraries. By RT-PCR and immunohistochemistry, we found that IGFBP7 was overexpressed in CRC tissue compared to normal tissue. However, our in vitro experiments performed in 10 CRC cell lines showed that IGFBP7 expressed only in SW480 and Caco2 cell lines, which implied an underlying reversible regulatory mechanism. Using methylation-specific PCR (MSP) and bisulfite sodium PCR (BSP), we found that its expression was associated with DNA hypomethylation of exonl. This was further supported by the in vitro study which showed restored IGFBP7 expression after demethylation agent 5-aza-2'-deoxycytidine treatment. Correlation analysis between IGFBP7 expression and prognosis indicated that overexpression of IGFBP7 in CRC tissue correlated with favourable survival. Investigation of the functional role of IGFBP7 through transfection studies showed that IGFBP7 protein could inhibit growth rate, decrease colony formation activity, and induce apoptosis in RKO and SW620 cells, suggesting it a potential tumor suppressor protein in colorectal carcinogenesis. In conclusion, our study clearly demonstrated that IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis and its expression is associated with DNA hypomethylation of exon 1.展开更多
Currently there is considerable interest among oncologists to find anticancer drugs in Chinese herbal medicine (CHM). In the past, clinical data showed that some herbs possessed anticancer properties, but western scie...Currently there is considerable interest among oncologists to find anticancer drugs in Chinese herbal medicine (CHM). In the past, clinical data showed that some herbs possessed anticancer properties, but western scientists have doubted the scientific validity of CHM due to the lack of scientific evidence from their perspective. Recently there have been encouraging results, from a western perspective, in the cancer research field regarding the anticancer effects of CHM. Experiments showed that CHM played its anticancer role by inducing apoptosis and differentiation, enhancing the immune system, inhibiting angiogenesis, reversing multidrug resistance (MDR), etc. Clinical trials demonstrated that CHM could improve survival, increase tumor response, improve quality of life, or reduce chemotherapy toxicity, although much remained to be determined regarding the objective effects of CHM in human in the context of clinical trials. Interestingly, both laboratory experiments and clinical trials have demonstrated that when combined with chemotherapy, CHM could raise the efficacy level and lower toxic reactions. These facts raised the feasibility of the combination of herbal medicines and chemotherapy, although much remained to be investigated in this area.展开更多
文摘目的:探究衰弱对社区获得性肺炎患者的临床疗效及生活质量的影响。方法:选取2022年1月至2023年8月期间我院收治的60例获得性肺炎患者作为研究对象。按照患者的衰弱表型评估方法(Fried衰弱评估)评分是否小于3分将患者分为非衰弱组(n=23)和衰弱组(n=37)。根据《中国成人社区获得性肺炎诊断和治疗指南》的建议,对患者采取相应的治疗措施。比较两组患者临床疗效、临床症状消退时间、肺功能[第1秒用力呼气量(First second forced expiratory volume,FEV1)、用力肺活量(Forced vital capacity,FVC)及FEV1与FVC的比值(Ratio of FEV1 to FVC,FEV1/FVC)]、生活质量[生活质量量表(SF-36)]的差异。结果:治疗后4 w,衰弱组的总有效率明显低于非衰弱组(P<0.05);衰弱组患者的临床症状消失时间明显长于非衰弱组(P<0.05);两组患者FEV1、FVC、FEV1/FVC肺功能明显高于治疗前,但衰弱组明显低于非衰弱组(P<0.05);衰弱组患者的生活质量指标评分明显低于非衰弱组(P<0.05)。结论:针对社区获得性肺炎患者,衰弱对临床疗效有负面影响,会延长患者的临床症状消退时间,影响患者肺功能恢复,降低患者的生活质量。
基金Project (Nos. 30200333 and 30570840) supported by the NationalNatural Science Foundation of China
文摘Insulin-like growth factor binding-protein-7 (IGFBP7) was obtained from our previous colonic adenocarcinoma (CRC) and normal mucosa suppression subtraction hybridization (SSH) cDNA libraries. By RT-PCR and immunohistochemistry, we found that IGFBP7 was overexpressed in CRC tissue compared to normal tissue. However, our in vitro experiments performed in 10 CRC cell lines showed that IGFBP7 expressed only in SW480 and Caco2 cell lines, which implied an underlying reversible regulatory mechanism. Using methylation-specific PCR (MSP) and bisulfite sodium PCR (BSP), we found that its expression was associated with DNA hypomethylation of exonl. This was further supported by the in vitro study which showed restored IGFBP7 expression after demethylation agent 5-aza-2'-deoxycytidine treatment. Correlation analysis between IGFBP7 expression and prognosis indicated that overexpression of IGFBP7 in CRC tissue correlated with favourable survival. Investigation of the functional role of IGFBP7 through transfection studies showed that IGFBP7 protein could inhibit growth rate, decrease colony formation activity, and induce apoptosis in RKO and SW620 cells, suggesting it a potential tumor suppressor protein in colorectal carcinogenesis. In conclusion, our study clearly demonstrated that IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis and its expression is associated with DNA hypomethylation of exon 1.
基金Project (No. 011107607) supported by the Science and TechnologyFoundation Grant of Zhejiang Province, China
文摘Currently there is considerable interest among oncologists to find anticancer drugs in Chinese herbal medicine (CHM). In the past, clinical data showed that some herbs possessed anticancer properties, but western scientists have doubted the scientific validity of CHM due to the lack of scientific evidence from their perspective. Recently there have been encouraging results, from a western perspective, in the cancer research field regarding the anticancer effects of CHM. Experiments showed that CHM played its anticancer role by inducing apoptosis and differentiation, enhancing the immune system, inhibiting angiogenesis, reversing multidrug resistance (MDR), etc. Clinical trials demonstrated that CHM could improve survival, increase tumor response, improve quality of life, or reduce chemotherapy toxicity, although much remained to be determined regarding the objective effects of CHM in human in the context of clinical trials. Interestingly, both laboratory experiments and clinical trials have demonstrated that when combined with chemotherapy, CHM could raise the efficacy level and lower toxic reactions. These facts raised the feasibility of the combination of herbal medicines and chemotherapy, although much remained to be investigated in this area.